In this issue:
Atorvastatin for CVE prevention in RA
Physical activity is a protective, modifiable factor against RA
CNTX-4975 may provide relief from knee OA pain
Fatty fish consumption may reduce the symptom burden from gout flares
Secukinumab is more cost effective than adalimumab for AS in Korea
No benefit to biologic holiday before arthroplasty
Glucocorticoids double the risk of shingles in tofacitinib-treated RA
Radiographic versus nonradiographic axial spondylarthritis
Methotrexate versus biologics as first-line treatment in RA
Please login below to download this issue (PDF)